Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Press Release Jun 01 2021

· Issued by Glenmark Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-jun-01-2021-4

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 01, 2021, titled "Glenmark Pharmaceuticals launches Rufinamide Tablets USP, 200 mg and 400 mg".

View Attachment

6ix hasn’t read this filing yet.

Glenmark Pharmaceuticals Limited on 6ix

Earlier from Glenmark Pharmaceuticals

Later from Glenmark Pharmaceuticals

All Glenmark Pharmaceuticals news releases